Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc. financial statements

Spyre Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 010-K
Net income−USD 155.2M10-K
Cash and equivalentsUSD 85.72M10-Q

Spyre Therapeutics, Inc. financials on 6ix · Spyre Therapeutics, Inc. on 6ix